Intermediate steps in the aromatization of C-androstene-3,17-dione to e&one, catalyzed by human placental microsomes, have been evaluated through the use of normal and hypothetical intermediate compounds as substrates and the oxidases involved have been characterized by the effects of oxygen and carbon monoxide upon these conversions. When air was replaced by a 5 % oxygen-95 % nitrogen atmosphere, the rate of aromatization of 4-androstene-3,17-dione or of lQ-hydroxy-4-androstene-3,17-dione was reduced 30 to 35% while no inhibition occurred if 3,17-dioxo-4-androsten-lQ-al was the substrate. The aromatization of all three of these steroids in 5 % oxygen was not inhibited when carbon monoxide was added at a concentration 8.8 times that of oxygen. However, this same CO: O2 ratio of 8.8 decreased the aromatization of 4-estrene-3,17-dione 51 to 95% and the aromatization of 1,4-androstadiene-3,17-dione 10 to 16%. Hydroxylation of the A ring of 4-estrene-3,17-dione was also inhibited by carbon monoxide to the same extent as was its aromatization. These findings have been interpreted as evidence for the existence of three mixed function oxidases active in steroid aromatization, one of which may be a form of cytochrome P-450.
The aromatization of androstenedione' to estrone, catalyzed by human placental microsomes is a complex conversion involving both demethylation and desaturation. Requirements for both O2 and TPNH (1) suggest the participation of an enzyme of the mixed function oxidase type (2). Demonstrations of 19-oxygenated intermediates, 19-hydroxyandrostenedione * This work was supported by United States Public Health Service Grants HD 00024 and HD 03055. and bv Ford Foundation Grant 67-135.
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(s-5), and 19-oxoandrostenedione (6, 7), indicate a multistep reaction sequence (Scheme 1). But findings of identical requirements for 02 and TPNH for the aromatization of all intermediates (6, 7), provide no discrimination as to the number of oxidases participating in the over-all conversion. We have previously reported that cytochrome P-450, a component of many mixed function oxidase systems utilizing steroid substrates Q-13), is present in placental microsomes but appears not to function as the oxidase component in the ratelimiting step of aromatization since CO failed to inhibit the over-all conversion of androstenedione to estrone under conditions of limiting 02 supply (14) . We have now extended this study to examine each known intermediate step in the aromatization sequence, utilizing O2 and CO atmospheres to expose the properties of the participating oxidase. A preliminary report of some of our findings has already appeared (15).
EXPERIMENTAL PROCEDURES
Solvents used for routine extractions and chromatography were reagent grade; those used for purification, crystallization, or solution of steroid substrates were redistilled or were of spectroscopic quality.
TPNH was prepared by chemical reduction of TPNf (P-L Biochemicals) with the method of Kaplan, Colowick, and Neufeld (16) . Glucose 6-phosphate dehydrogenase (EC 1 .l .1.49) was obtained from Boehringer Mannheim.
Gas mixtures were prepared and analyzed by The Matheson Company, Inc., East Rutherford, New Jersey.
Steroid Xubstrates-Androstenedione and 1,4-androstadienedione were purchased from Sigma. The latter was recrystallized four times from benzene and once from cyclohexane. Substrate solutions of the purified material were prepared just prior to each incubation.
4-14C-19-Norandrostenedione was prepared by allowing a 1 mu solution of 4-14C-17fl-hydroxy-4-estren-3-one (AmershamSearle, Des Plaines, Illinois; specific activity 50.2 mCi per mmole) in glacial acetic acid to react with a molar excess of CrOo for 5 min at room temperature.
The 4-'*C-19norandrostenedione formed was purified by paper chromatography in System I and was diluted with unlabeled Step III SCHEME 1 drostenedione (Ikapharm, Ramat-Gan, Israel) by the CrO,-pyridine-oxidation method (17, 18). The product was purified by paper chromatography in System I. It exhibited an absorption maximum at 243 nm, gave a positive Zimmermann reaction and was readily converted to estrone by placental microsomes and TPNH.
At 0" it was reduced by NaBHa in methanol to a product which absorbed ultraviolet light and which corresponded to a reference sample of 17p, 19-dihydroxy-4-androsten-3-one (cf. Reference 6) in its mobility on thin layers of Silica Gel G in three solvent systems (chloroform-methanol (19 : 1) ; diethyl etheracetone (1: 1) ; ethyl acetate).
vidual estrogens resolved by paper chromatography in System II. Estrone or 17fl-estradiol were then used as standards for the appropriate estrogen fractions.
In addition, fluorometric findings were confirmed semiquantitatively by chromatography of steroid fractions on thin layers of Silica Gel G in diethyl ether-benzene (2 : 1). Estrogens were detected and characterized by their reactivity with both the FeC1a-K3Fe(CN)6
(23) and HnSO1-ethanol (5) reagents.
The purity of all steroids used as substrates was confirmed by thin layer or paper chromatography.
Tissue Preparation--Microsomal fractions from human term placentas were prepared as previously described (1) and were stored frozen. lUicrosoma1 protein was determined by the turbidimetric procedure of Kunitz (19) standardized against the method of Lowry et al. (20) .
Aromatization Incubations-Steroids were dissolved in 95% ethanol at a concentration of 2 mg per ml and 0.05 ml was added as the final component to a mixture, maintained at O", containing 4 to 21 mg of microsomal protein, 100 pmoles of potassium phosphate (pH 7.05), 10 pmoles of TPNH, 100 pmoles of glucose 6-phosphate, and 14 units of glucose 6-phosphate dehydrogenase. The final volume was 2.5 ml. AI1 reaction mixtures were equilibrated with prepurified N2 before addition of the experimental gas mixtures as previously described (14) . Incubation was carried out in the dark at 37" for 30 min. Rates of aromatization were constant during this time period.
The reaction was terminated by mixing with CHC& and freezing.
Control flasks containing all components, except substrate solute, were included in every experiment.
Additional control mixtures containing substrate but incubated under Nz were also run in some experiments.
Processing of &rJC-19-Norandrostenedione
Incubation Mixtures and Characterization of Products-Chloroform extracts were purified with the hexane-90% methanol partition step and then fractionated by paper chromatography in System II. No estrone (RF 0.74) was found but 176.estradiol (RF 0.38) was detected and was retained in the phenolic fraction on further purification.
After quantitative assay it was rechromatographed in System II and shown to have the same mobility as an authentic sample as determined both by detection of radioactivity and reactivity with the FeC13-KzFe(CN)e reagent.
No contaminants could be detected by either method.
A second, polar, metabolite (RF 0.23) of 19-norandrostenedione was also detected in the initial chromatogram in System II. It had the mobility expected for the lp-or 2fi-hydroxylated products indicated by Townsley and Brodie (24) and Brodie, Pillai, and Hay (25) . It had a reactivity in the acid fluorescence assay comparable to estrone and on treatment with 1 N NaOH for 3 hours at room temperature it yielded a product which displayed a mobility identical with that of estrone (RF 0.74, System II; RF 0.51, System I) when detected by reactivity with FeC13-K3Fe(CN) 6 and by localization of radioactivity.
The A ring-hydroxylated metabolite and estradiol were formed in a ratio of 1.7 (cJ Reference 24). Radioactivity was detected on paper chromatograms with a Packard model 7201 scanner and was measured quantitatively by liquid scintillation spectrometry as previously described (14) . Processing of Incubation Mtitures-Products were extracted with CHCl, as previously described (1). High estrogen titers could be measured directly in the crude CHC13 extract.
To assay low levels of estrogens, impurities were first removed by extracting the CHC13 residue, dissolved in methanol-water (9 : l), three times with 3 volumes of hexane, or by partitioning between toluene and 1 N NaOH, or both (21): At least one experiment with each substrate was processed through this isolation of phenolic material.
Paper Chromatography-Chromatographic development was carried out at room temperature.
Solvent systems contained ligroin-toluene-methanol-water in the following proportions by volume: System I, 9:1:8.5:1.5; System II, 5:5:8.5:1.5.
Whatman No. 1 filter paper, washed with 2 N acetic acid, water, and methanol as recommended by Axelrod (26), was used whenever steroids were later to be eluted. Absolute methanol was the eluting solvent.
Estrogen Assay-Total estrogens were assayed fluorometrically by the Preedy and Aitken (22) previous study (14) had been carried out under reduced 02 tension, we compared the relative reactivities of these substrates in air and in 5% 02. Results of these experiments are presented in Table I . In air, the expected pattern of relative activities was observed. However, the effectiveness of the 19-0x0 compound as a substrate for aromatization was more striking than had been indicated by previous studies which had not measured initial reaction rates (6, 7, 18). In 5% 02, as well, a progressive increase in effectiveness as substrate followed the sequential oxidations at C-19 of the Cl9 steroids.
Therefore, within this range of 02 concentrations, the rate-limiting step measured in the aromatization of androstenedione will be its hydroxylation at C-19 (Step I, Scheme 1) and the rates of aromatization of 19-hydroxyandrostenedione and of 19.oxoandrostenedione will each measure a different and distinct intermediary step of the aromatization process (Step II, a or b and Step III, respectively). Table II . All incubations were carried out in 5% 02 and CO was used at a concentration 8.8 times that of 02. We have previously reported that under these conditions CO caused no inhibition of the aromatization of androstenedione (14) . Table II indicates that this is also true when the normal 19-oxygenated intermediates are used as substrates.
Thus no CO sensitivity could be shown for the oxidase operating at either Steps I, II, or III.
Since the aromatization of all three of these compounds still involves both the removal of C-19 and the dehydrogenation of the A ring, we attempted to study these events independently by using as model substrates, steroids which need undergo only one or the other of these processes to produce an aromatic A Table II , aromatization of l,Pandrostadiene-3, 17-dione, which requires only demethylation (and rearrangement) to yield estrone, is inhibited by CO only to a very limited extent while aromatization of 19-norandrostenedione, which involves only dehydrogenation, is markedly inhibited by CO.
Townsley and Brodie (24) and Brodie et al. (25) showed that 19norandrostenedione can undergo enzymatic hydroxylation in ring A under the incubation conditions of the aromatization assay and they have pointed out that these hydroxylated products can also give rise to aromatic steroids by acid or base catalyzed dehydrations.
Such a nonenzymatic generation of estrone could occur during the fluorescence assay of unfractionated extracts or during the alkali partition used for purification of the reaction products.
Therefore, additional incubations were carried out with 4-I%-19-norandrostenedione as substrate. Hydroxylated and aromatic products were fractionated by paper chromatography to prevent nonenzymatic aromatization and results from the fluorescence assay were checked by measurements of radioactivity.
In two experiments, each with duplicate pairs of flasks, CO was found to inhibit the enzymatic aromatization of 19-norandrostenedione 88 to 94oj, while the conversion to the hydroxylated metabolite or metabolites was also reduced to the same extent.
DISCUSSION
Current knowledge concerning the intermediate steps of estrogen biosynthesis from Cl9 steroid precursors is summarized by Scheme 1. Hydroxylation at C-19 is the first, and an obligatory step in the aromatization of androstenedione (3-5). 19-Oxoandrostenedione can also serve as an intermediate (6, 7), but a mandatory role has yet to be established and alternative pathways (Step II, a and b) are therefore depicted for the conversion of the 19-hydroxylated compound to estrone. Under usual experimental conditions, these intermediates do not accumulate, since each step can occur more rapidly than the one preceding it in the sequence. This has permitted our use of intermediates as substrates to measure rates of discrete segments of the complete aromatization reaction. Each intermediate step, so far distinguished, shares the same requirements for O2 and TPNH characteristic of the over-all conversion but could potentially be catalyzed by a unique mixed Enzymatic Aromatization of Steroids. I Vol. 246, No. 1 function oxidase. We have investigated the effects of O2 and CO on each of these separate steps in order to define the enzymatic properties of the oxidase system involved.
Our studies with CO provide no differentiation of oxidase activities at Steps I, II, or III.
Aromatization of androstenedione, 19-hydroxyandrostenedione, and 19-oxoandrostenedione are all insensitive to this reagent under our experimental conditions.
There is, therefore, no evidence for the participation of cytoehrome P-450 at any stage of the aromatization sequence. The lack of inhibition by CO even when O2 supply is rate limiting would preclude cytochrome P-450 as a participant in the oxidations occurring at C-19 during Steps I and IIa. Gaylor and Mason (29) have also found that cytochrome P-450 does not serve as an oxidase in the oxidative demethylation of 4a-methylsterols, a multi-step process which also is initiated by an aerobic hydroxylation of a methyl group attached to a steroid ring.
A difference in oxidase properties is discernible, however, in incubations carried out under reduced O2 tension.
Aromatization of the 19-0x0 intermediate is selectively insensitive to low O2 levels. Thus the oxidase acting at Step III appears to be characterized by a higher affinity for O2 and can be differentiated from that promoting either Steps I or II.
No discrimination between oxidase activities at Steps I and II has been possible, however, since the aromatization of androst.enedione and 19.hydroxyandrostenedione are both inhibited to the same degree when 02 supply is restricted.
Akhtar and Skinner (6) have postulated that Step II may actually be a second hydroxylation of C-19. If this is true, a single 19-hydroxylase might well promote both Steps I and IIa.
The attempt to resolve artificially the demethylation and dehydrogenation components of the aromatization process through the use of 1,4-androstadiene-3,17-dione and 19norandrostene-dione as model substrates has revealed effects of CO not encountered when the aromatization of the normal intermediates was examined.
Thus a third oxidase of placentral microsomes involved in the aromatization of 19.norandrostenedione can be defined by its CO sensitivity.
By use of Warburg's partition equation (30) , partition constants ranging from 0.56 to 1.2 were calculated for this oxidase from the extent of inhibition obtained when 4J4C-19.norandrostenedione was used as substrate and products were extensively purified.
These results are in good agreement with values obtained by others for a number of cytochrome P-450-catalyzed steroid oxidations (8-13).
Since the aromatization of 19-norandrostenedione involves a stereospecific loss of the same l&hydrogen eliminated during the aromatization of both androstenedione and 19-hydroxyandrostenedione (31, 32) , it has been assumed that the aromatization of 19-norandrostenedione would serve as a model for the dehydrogenation occurring during the aromatization of the Cl9 steroids.
The contradictory effects of CO which we have observed with these two systems can be explained in several ways.
The CO-sensitive oxidase, detected when 19-norandrostenedione is the substrate, might also promote the dehydrogenation of CL9 steroids as part of Step III (or IIb) if it could catalyze this conversion at a rate at least 10 times that of the rate-limiting event of
Step III.
Under such circumstances, a 90% inhibition of the CO-sensitive component would still not limit the over-all efficiency of the Step III conversion and thus would go undetected.
Alternatively the aromatization of Cl8 and Cl9 steroids may be distinct metabolic processes and may share no common mechanism or catalyst.
In this regard, it is interesting that the unique formation of the A ring hydroxylated metabolite or metabolites (24, 25) of 19-norandrostenedione is also inhibited by CO and to the same extent as is its aromatization.
The suitability of 1,4-androstadienedione as a model substrate for C-19 demethylation is even less secure. It is not known whether, as with other Cls steroids, 19-hydroxylation is an obligatory or rate-limiting feature of its conversion. Nor, if 19-oxygenated intermediates are formed, is it known whether enzymatic or nonenzymatic (33) (34) (35) processes are responsible for their subsequent aromatization.
The limited inhibition by CO observed with this substrate, therefore, can not be interpreted decisively. It could result from (a) the inhibition of a rate-limiting oxidase having a low affinity for carbon monoxide, (b) the inhibition of a CO-sensitive but nonrate-limiting step in a reaction sequence to the point where it did become rate limiting, or (c) the summation of effects on a major COinsensitive pathway and a parallel or competing, minor, COsensitive pathway.
We have interpreted our experimental results as giving evidence for the existence of multiple oxidases participating in steroid aromatization.
Physical fractionation of these proposed microsomal components eventually will be required to validate their independent existence. Aclcnowledgment-We wish to thank Mrs.
-Miriam Dixon for
